Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases

Table 2 Drug indication and the status of dose appropriateness of DOAC in the medical error reports

Drug indication		DOAC type			Statistical test*	p
Drug indication		Apixaban (n = 134)	Dabigatran (n = 28)	Rivaroxaban (n = 37)	Statistical test*	p
	Atrial fibrillation	73 (54.5%)	13 (46.4%)	27 (73.0%)
	Deep vein thrombosis	34 (25.4%)	13 (46.4%)	8 (21.6%)
	Cerebral venous thrombosis	2 (1.5%)	0 (0.0%)	0 (0.0%)	12.883	0.115
	Pulmonary embolism	17 (12.7%)	1 (3.6%)	2 (5.4%)
	Others	8 (6.0%)	1 (3.6%)	0 (0.0%)

ISSN: 2052-3211